Ossia M Eichhoff

8PUBLICATIONS
80CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical mycologyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 06, 2025
Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant Melanoma.

Flavia L Tellenbach, Luzia Seiler, Mark Johnson

|Apr 17, 2025
Protein Kinase C Inhibition Overcomes Targeted Therapy Resistance in Cutaneous Melanoma.

Corinne I Stoffel, Ossia Eichhoff, Phil F Cheng

|Oct 20, 2023
Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy.

Nina Zila, Ossia M Eichhoff, Irene Steiner

|Mar 22, 2023
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma.

Ossia M Eichhoff, Corinne I Stoffel, Jan Käsler

|Feb 22, 2022
A DNA replication-independent function of pre-replication complex genes during cell invasion in C. elegans.

Evelyn Lattmann, Ting Deng, Michael Walser

|Oct 14, 2021
Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma Progression.

Annalisa Saltari, Andreas Dzung, Marika Quadri

Pageof 2

Frequent Collaborators

5 joint publications

Reinhard Dummer

5 joint publications

Phil F Cheng

3 joint publications

Andreas Dzung

3 joint publications

Mitchell P Levesque